Benelux Precision Medicines Forum
Benelux Precision Medicine Forum will bring together those at the very forefront of precision medicine from biologists, physicians and technology developers to data scientists, patient groups, governments and more. Hear Government talk about their vision for healthcare in the coming years, discover the latest technologies and how they are enabling a sea change in the way we treat patients and disease, learn more about the critical role of biomarkers and the latest innovations in diagnostics.
The results of an evidence-based analysis conducted by Charles River Associates on behalf of the European Biopharmaceutical Enterprises (EBE) and The European Federation of Pharmaceutical Industries and Associations (EFPIA), to characterise and quantify the benefits of personalised medicines to patients, society and healthcare systems, will be presented during the forum. This study seeks to identify barriers and enablers to the development and adoption of PM in Europe and elaborate strategic recommendations for decision-makers to overcome these barriers and incentivise the development and adoption of PM in Europe.
The preliminary agenda of the event is available here.